Protalix BioTherapeutics, Inc. reports

Company identity 1 fact
Location
Hackensack, NJ
SEC filing record 1 fact
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 1-25 of 671 matching filings.

Per page
25
Current page
1
ARS File 001-33357

ARS

Filing date
30 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A

Filing date
30 Apr 2026
Reporting date
25 Jun 2026
Next action
Verify source filing
3/A

3/A filing

Filing date
27 Apr 2026
Reporting date
24 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-50118

SCHEDULE 13G/A filing

Filing date
30 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-50118

SCHEDULE 13G filing

Filing date
04 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
03 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
03 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
03 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
03 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2025
Reporting date
03 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .